TABLE 3.
Antibiotic | MIC (μg/ml)a |
No. (%) of strains |
||||
---|---|---|---|---|---|---|
50% | 90% | Range | Susceptible | Intermediate | Resistant | |
Penicillinb | 2 | 4 | <0.03->8 | 25 (24.5) | 7 (6.9) | 70 (68.6) |
Amoxicillin-clavulanic acid | <2/1 | >8/4 | <2/1-8/4 | 68 (66.7) | 5 (4.9) | 29 (28.4) |
Cefotaxime | 1 | 2 | <0.06->2 | 64 (62.7) | 32 (31.4) | 6 (5.9) |
Tetracycline | ≥8 | ≥8 | <0.5->8 | 25 (24.5) | 1 (1.0) | 76 (74.5) |
Chloramphenicol | 4 | 8 | <2->16 | 68 (66.7) | 0 (0) | 34 (33.3) |
Levofloxacin | 1 | 1 | <0.5-1 | 102 (100.0) | 0 (0) | 0 (0) |
Gatifloxacin | <0.5 | <0.5 | <0.5 | 102 (100.0) | 0 (0) | 0 (0) |
Moxifloxacin | <0.25 | <0.25 | <0.25-1 | 102 (100.0) | 0 (0) | 0 (0) |
Erythromycin | >2 | >2 | >2 | 0 (0) | 0 (0) | 102 (100.0) |
Azithromycin | >2 | >2 | >2 | 0 (0) | 0 (0) | 102 (100.0) |
Linezolid | 1 | 1 | 0.5-2 | 102 (100.0) | 0 (0) | 0 (0) |
Clindamycin | >2 | >2 | <0.06->2 | 31 (30.4) | 2 (2.0) | 69 (67.6) |
Vancomycin | <0.5 | <0.5 | <0.5-1 | 102 (100.0) | 0 (0) | 0 (0) |
SXTc | >4/76 | >4/76 | <0.5/9.5-4/76 | 23 (22.6) | 18 (17.6) | 61 (59.8) |
Meropenem | 0.5 | 1 | <0.25-1 | 34 (33.3) | 33 (32.4) | 35 (34.3) |
50% and 90%, MIC50 and MIC90, respectively.
Susceptible, intermediate, and resistant MIC breakpoints for penicillin were ≤0.06, 0.12-1, and ≥2 mg/liter, respectively.
SXT, trimethoprim-sulfamethoxazole.